Treatment of Fibromyalgia
Start with aerobic and strengthening exercise as first-line therapy, followed by patient education; only add pharmacological treatment if non-pharmacological approaches prove insufficient. 1
Graduated Treatment Algorithm
The EULAR 2017 guidelines provide the most authoritative framework, emphasizing a stepped approach that prioritizes safety, cost, and patient preference 1:
Stage 1: Initial Management (Non-Pharmacological - REQUIRED FIRST)
Aerobic and strengthening exercise is the ONLY therapy with a "strong for" recommendation (100% expert agreement, Level Ia evidence) 1. This should be:
- Individualized and graded physical exercise
- Can be combined with hydrotherapy or acupuncture 1
Patient education with written materials about the condition is mandatory at diagnosis 1
Stage 2: If Insufficient Response - Add Psychological/Physical Therapies
All carry "weak for" recommendations but have Level Ia evidence 1:
- Cognitive behavioral therapy (100% agreement) - particularly for comorbid mood disorders or unhelpful coping strategies 1
- Multicomponent therapies (93% agreement) - combining educational/psychological therapies with exercise 1
- Physical therapies: Acupuncture or hydrotherapy (93% agreement) 1
- Meditative movement therapies: Qigong, yoga, tai chi, or mindfulness-based stress reduction (71-73% agreement) 1
Stage 3: If Still Insufficient - Add Pharmacological Treatment
All pharmacological options carry "weak for" recommendations - meaning modest effect sizes 1. Choose based on dominant symptoms:
For Severe Pain or Sleep Disturbance:
- Amitriptyline (low dose) - 100% agreement, Level Ia 1
- Pregabalin - 94% agreement, Level Ia 1
- Cyclobenzaprine - 75% agreement, Level Ia 1
For Comorbid Depression or Severe Fatigue:
- Duloxetine or Milnacipran - 100% agreement, Level Ia 1
For Severe Pain Requiring Analgesia:
- Tramadol - 100% agreement, Level Ib 1
Critical caveat: NSAIDs and opioids have NOT demonstrated benefits for fibromyalgia and should be avoided 2
Stage 4: If Severe Disability Persists
Multimodal rehabilitation program combining multiple therapies 1
Key Clinical Pitfalls to Avoid
Do NOT start with medications - The guidelines unanimously (100% agreement) recommend initial focus on non-pharmacological therapies based on availability, cost, safety, and patient preference 1
Do NOT use opioids or NSAIDs - These lack evidence of benefit in fibromyalgia 2
Do NOT delay diagnosis - Prompt diagnosis with comprehensive assessment of pain, function, and psychosocial context is essential 1. Fibromyalgia is NOT a diagnosis of exclusion 3
Avoid monotherapy expectations - No single drug addresses the full spectrum of fibromyalgia symptoms (pain, fatigue, sleep disturbances, depression) 4. Effects are modest and often short-lived 1
Evidence Quality Considerations
The 2017 EULAR guidelines 1 represent the highest quality evidence available, based on systematic reviews and meta-analyses of 107 reviews from 2979 titles. This moved fibromyalgia management from predominantly expert opinion to firmly evidence-based recommendations 1.
Important limitation: While exercise has strong evidence, all other therapies (including all medications) have only weak recommendations despite Level Ia evidence, reflecting modest effect sizes 1. Recent reviews from 2024-2025 5, 6, 2, 7, 3 confirm these recommendations remain current, with no major new therapies emerging that would change the algorithm.
Emerging but Unproven Options
Cannabinoids, vitamin D supplementation, and medical cannabis show promise but remain controversial with insufficient evidence 6, 7. These should not be first-line choices.